TUESDAY, June 25, 2024 (HealthDay News) — A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce theContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial results show. Seven out of 12 patients no longer needed daily insulin shots after receiving a full dose of the gene therapy,Continue Reading
MONDAY, June 24, 2024 (HealthDay News) — Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. Patients using inhaled insulin (Afrezza) plus long-lasting insulin degludec injections had better control over their blood sugar than those assignedContinue Reading
THURSDAY, June 13, 2024 (HealthDay News) — People with type 1 diabetes are 25% less likely to die early now than they were in 1990, a new global tally finds, and the number of people who’ve lived into their senior years with the autoimmune illness keeps rising. The new findingsContinue Reading
WEDNESDAY, June 11, 2024 (HealthDay News) — Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and midnight appeared to be better at controlling blood sugar levels all day long, according to resultsContinue Reading
THURSDAY, June 6, 2024 (HealthDay News) — Common drugs used to control cholesterol, blood sugar and high blood pressure might also lower a person’s risk of stroke, a new study finds. The researchers evaluated the risk of brain aneurysms that cause bleeding strokes in patients. For the study, they lookedContinue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they feared theContinue Reading
THURSDAY, May 23, 2024 (HealthDay News) — Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, OzempicContinue Reading
FRIDAY, May 17, 2024 (HealthDay News) — Men are more vulnerable than women to the debilitating effects of diabetes, a new long-term study finds. Overall rates of diabetes are similar between men and women, according to the report published May 16 in the Journal of Epidemiology & Community Health. ButContinue Reading
THURSDAY, May 9, 2024 (HealthDay News) — The U.S. Food and Drug Administration has issued a Class 1 recall — its most urgent kind — for an IOS app linked to a specific kind of insulin pump used by people with diabetes. The recall notice, which the FDA says isContinue Reading